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IS BALWCN ANGIOPLASTY USING A TERUMO WIRE SUPERIOR TO 
LASER ANGIOPIASTY OF CHRONIC TOTAL CCCLUSION IN PERIPHERAL 
ARTERIES? 
Yoseph Shalev, Donald H. Schmidt, 
University of W;sconsin (#CC), Milwaukee. WI, USA. 
We compared the primary suxess rate and the outcome of 
balloon angioplasty using a Terumo wire (PBA-T) wfth 
peripheral laser balloon angioplasty (PLA) in long chronic 
total occlusions. Pts were alternately assigned to PLA or 
PBA-T irrespective of clinical or angiographic variables. 
Group I: 30 pts (20 males and 10 females; age 72.5+8 yrs) 
in whom PLA (argon laser, bared-tip catheter; IMTAC, GV 
Medical Inc.) was the only approach. Group II: 38 pts (30 
males and 8 females; 69.4210.1 yrs) in whom PEA-T was the 
only approach. All pts had life style limiting 
claudication (~2 blocks); other clinical parameters ie. 
smoking, diabetes mellitus, calcification of arteries were 
similar in both groups. 
Grxp I Group II P Value 
(N-30) (N-38 j 
I "Lesion Length (cm) 14.696.3 15.357.9 NS 
II Primary Success 60% 90% e.005 
III Procedure Time (min) 130+30 70+10 6.0001 
IV Ankle Brachial Index-Pre 0.5+17 0.47+131 
Post 0.85flO 0.84+12] C.001 
Complications: dissection, hematoma and distal emboliza- 
tion occurred infrequently (1%) and was not different in 
both groups. We conclude that: 1) Primary success rate of 
PBA-T in chronic total occlusions of peripheral arteries 
is much higher than PLA. 2) the procedure time wit!. PBA-T 
was significantly shorter. Therefore, we feel PBA-T is 
superior to PLA in chronic total occlusions of peripheral 
arteries. 
ASSESSEMENT OF RESTENOSIS WS PRIMARY LESIONS IN 
PATIENTS WITH PERIPHERAL VASCULAR DISEASE USING IN SITU 
HYBRIDIZATION AND GENE EXPRESSION OF TWO NONMUSCLE 
MYOSIN ISOFORMS. 
Lawrence Weir, Michael Srmons, Marianne 
eth Rosenfield and Jeffrey F¶. Isner, Tufts 
University School of Medicine, St.Elizabeth's Hospital, 
Boston, p/IA. 
These studies were designed to examine gene expression 
by in situ hybridization (ISH) to identify genes that 
are activated in restenosis vs primary lesions in pts 
witn peripheral vascular disease (PVD). The nonmuscle 
myosin heavy chain gene (MMMHC) is a good candidate 
since it has been shown that smooth muscle cells 
express preferentially NMMRC, as opposed tc smooth 
muscle myosin, during proliferation. We analyzed at the 
level of gene transcription the expression of two 
recently cloned isoforms of human WMMHC (NMMHC-A and 
the differential function of which is under 
in specimens obtained percutaneously by directed 
atherectomy in 5 pts with symptomatic PWD. A total of 
165 9grm frozen sections of fresh stenotic lesions 2 
restenosis (64 sections) and 3 primary lesions C;Ol 
sections) were studied by ISH using RNA antisense 
probes specific for messenger RNA (mRNA) of each NMMHC 
isoform. The specificity of ISH was controlled on 
serial sections by using a noncomplementary sense 
probe. The restenosis lesions consistently showed 
trong hybridization with each NPPMHC isoforms antisense 
robe with a clustering of 220 grains/cell nucleus in 
ore than 80% of total cells on 100x mag fields 
selected at random and analyzed using a semi-quantitative 
scoring system; NMMHC-A and MC-B mRNA were much less 
intensely expressed in primary lesions as evidenced by 
rare clustering of gr;ins over cell nucleus. Conclusions: 
these preliminary findings suggest that both NMMiC-A and 
MHC-B are activated in restenosis lesions and could 
prove to be markers for restenosis in pts with PVD. 
